Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Grace Trull"'
Autor:
Erin G. Major, Courtenay Gilmore Wilson, Delesha M. Carpenter, J. Chase Harless, Grace Trull Marley, Bayla Ostrach
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 9, Iss , Pp 100204- (2023)
Background: There are pharmacy-related barriers to the dispensing of buprenorphine for the treatment of opioid use disorders. These include pharmacists' moral objections and mistrust of treatment regimens; the perception of a limit on the amount of b
Externí odkaz:
https://doaj.org/article/da31b962a395473680384a697816c27a
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 4, Iss , Pp 100082- (2021)
Background: Buprenorphine access is limited for patients with opioid use disorder, especially in rural areas. Telephone audits have identified pharmacist limitations to the dispensing of buprenorphine particularly in independent pharmacies in compari
Externí odkaz:
https://doaj.org/article/24424d92cecf4477897e7e1fa396545a
Autor:
Major, Erin G., Wilson, Courtenay Gilmore, Carpenter, Delesha M., Harless, J. Chase, Marley, Grace Trull, Ostrach, Bayla
Publikováno v:
In Exploratory Research in Clinical and Social Pharmacy March 2023 9
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 4, Iss, Pp 100082-(2021)
Background Buprenorphine access is limited for patients with opioid use disorder, especially in rural areas. Telephone audits have identified pharmacist limitations to the dispensing of buprenorphine particularly in independent pharmacies in comparis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1501f9ba5437ea7f59ffe19823b99fe
http://www.sciencedirect.com/science/article/pii/S2667276621000822
http://www.sciencedirect.com/science/article/pii/S2667276621000822
Publikováno v:
Drug and Alcohol Dependence
Highlights • 20% of state Medicaid programs operate monthly prescription fill limit policies • Prescription fill limits may pose barriers to Medicaid-covered naloxone fills • Naloxone exemptions may improve naloxone access and prevent opioid ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90972458a9ec93b32f14108414cd4a2a
https://pubmed.ncbi.nlm.nih.gov/34298354
https://pubmed.ncbi.nlm.nih.gov/34298354
Autor:
Major EG; Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA., Wilson CG; Charles George Veterans Affairs Medical Center, 110 Tunnel Road, Asheville, NC 28805, USA.; UNC Eshelman School of Pharmacy, 1 University Heights, Asheville, NC 28804, USA., Carpenter DM; UNC Eshelman School of Pharmacy, 1 University Heights, Asheville, NC 28804, USA., Harless JC; Eastern Tennessee State University, 1276 Gilbreath Drive, Johnson City, TN 37614, USA., Marley GT; UNC Eshelman School of Pharmacy, 1 University Heights, Asheville, NC 28804, USA., Ostrach B; Boston University School of Medicine, 72 E Concord Street, Boston, MA, USA 02118.
Publikováno v:
Exploratory research in clinical and social pharmacy [Explor Res Clin Soc Pharm] 2022 Dec 26; Vol. 9, pp. 100204. Date of Electronic Publication: 2022 Dec 26 (Print Publication: 2023).